Ginsenoside Rb1 attenuates age-associated cognitive impairment by modulating oxidative stress and the SIRT1/eNOS/NO...

Area of Science:

• Gerontology
• Pharmacology
• Molecular Biology

Background:

• Ginsenoside Rb1 (Rb1), a compound from traditional Chinese medicine, is known to combat oxidative stress, autophagy, and apoptosis.
• The specific role of Rb1 in the natural aging process has not been previously elucidated.

Purpose of the Study:

• To investigate the effects of Rb1 on the natural aging process in mice.
• To explore the potential molecular mechanisms underlying Rb1's anti-aging properties.

Main Methods:

• Middle-aged and aged mice were treated with low or high doses of Rb1 for eight weeks.
• Changes in body weight, spatial learning, and brain tissue senescence were assessed.
• Oxidative stress markers, nitric oxide (NO) levels, and inflammatory markers (TNF-α, IL-6) were measured in serum and hippocampal tissue.
• Sirtuin 1 (SIRT1) protein expression was analyzed to identify key pathways.

Main Results:

• Rb1 treatment significantly mitigated age-related physiological decline, including weight loss and cognitive impairment.
• Mice receiving Rb1 exhibited reduced oxidative stress, evidenced by lower malondialdehyde (MDA) and higher superoxide dismutase (SOD) activity.
• Rb1 administration increased nitric oxide (NO) levels and enhanced Sirtuin 1 (SIRT1) protein expression, while reducing pro-inflammatory cytokines like TNF-α and IL-6.

Conclusions:

• Rb1 effectively delays the aging process in mice by alleviating oxidative stress and inflammation.
• The anti-aging benefits of Rb1 are associated with the modulation of the SIRT1/eNOS/NO signaling pathway.